Pyxis Oncology Inc Sustainability Reports
Pyxis Oncology Inc. is a clinical-stage biopharmaceutical company focused on developing therapies to treat aggressive cancers. The company's portfolio includes antibody-drug conjugates (ADCs) and immuno-oncology therapeutics designed to target tumor cells directly.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00PQFFCW4
2 reports from 2021 to 2022